Top 25 Interventional Radiology Companies by Transpire Insight

By Transpire Insight

---

Description

According to a research report published by Transpire Insight, the global interventional radiology market size is projected to grow from USD 33.5 billion in 2026 to USD 53.05 billion by 2035, at a CAGR of 9.20% during the forecast period 2026-2035. Rising prevalence of chronic diseases such as cancer and cardiovascular diseases, the fast-paced adoption of AI and robotics in image-guided procedures, and escalating global demand for minimally invasive interventions are all contributing to the market. Today's rapidly growing adoption of AI and robotics and the increasing prevalence of chronic diseases, including cancer and cardiovascular diseases, are driving the market.

Introduction

The interventional radiology market is a cutting-edge part of modern healthcare and deals with minimally invasive, image-guided therapies that are highly effective and can be used as an alternative to conventional open surgery procedures. Interventional radiologists are able to diagnose and treat these complex diseases at the source, using advanced imaging technology, including X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. Structural changes are sweeping this market, fueled by value-based reimbursement models, an aging global population, and the transition of care to cost-effective outpatient ambulatory surgical centers.

Recent Development News 

• January 2026: The global interventional radiology sector implemented the finalized FDA Quality System Regulation amendments, forcing manufacturing lines to harmonize documentation and medical device risk management with strict international ISO standards.

 

• May 2026: Siemens Healthineers secured FDA clearance for six next-generation interventional imaging systems engineered to significantly streamline workflow efficiency and optimize real-time guidance during complex image-guided operations.

Stay Ahead of Emerging Opportunities with Expert Market Insights by Transpire Insight

Transpire Insight provides comprehensive, data-driven market intelligence to support smarter business decisions. Our research is rooted in comprehensive analysis, authoritative predictions, and industry expertise, enabling organizations to make informed decisions in rapidly evolving markets. In-depth analysis of market segmentation, competitive positioning, regional trends, and emerging investment opportunities in high-growth areas. We blend accuracy with actionable intelligence, empowering companies to uncover new avenues for growth, bolster strategic decision-making, and stay ahead in a dynamic global market. 

Download the exclusive Interventional Radiology Market sample report today to uncover expert insights, emerging trends, and the opportunities defining the future of the industry.

Interventional Radiology Market Size & Statistics

• The market size for interventional radiology is estimated to be worth USD 33.5 billion in 2026.
• The market is going to expand at a CAGR of 9.20% between 2026 and 2035.
• The global interventional radiology market size is anticipated to reach USD 53.05 billion by 2035.
• North America is estimated to generate the highest demand during the forecast period, with a growth share of 41% in the interventional radiology market.
• Asia-Pacific is projected to grow the fastest during the forecast period at a CAGR of 7.1% in the interventional radiology market.

Regional Growth and Demand Analysis by Transpire Insight:

North America is expected to hold the highest market share during the forecast period in the interventional radiology market. The dominant player in the Interventional Radiology Market is North America, owing to the availability of leading players in terms of medical device manufacturing companies, healthcare technology suppliers, and robust investment in outpatient surgical facilities. The United States is currently the biggest producer in the interventional radiology market, considering factors such as the presence of extensive commercial manufacturing operations, efforts toward modernizing hospital imaging systems, and continued advancement in medical robotics engineering. As of 2026, some of the medical technology companies in the United States have undertaken production activities aimed at manufacturing superior interventional imaging systems that would enhance next-generation clinical and surgical outcomes.

Asia Pacific is anticipated to register the highest growth rate during the forecast period in the interventional radiology market. It is expected that the Asia-Pacific region will witness the highest growth rate during the forecast period due to increasing demand for affordable healthcare, growing fleets of specialized medical centers, increased healthcare infrastructure purchasing programs, and significant investment in regional hospital systems. China, India, Japan, and South Korea are some of the rapidly growing nations regarding healthcare infrastructure activities that drive the demand for advanced interventional radiology technologies. In 2026, there will be an increase in the facility modernization programs by many hospital chains in China and India. This was done with the aim of ensuring energy-efficient interventional radiology systems.

Top 15 Trends in the Interventional Radiology Market 

• Rapid shift from open surgery to minimally invasive procedures.
• AI-assisted real-time imaging guidance improves procedural accuracy.
• Rising oncology applications are driving embolization and ablation demand.
• Growth in office-based labs and outpatient imaging centers.
• Expanding the therapeutic catheter and consumables segment demand.
• North America leads in market share; Asia-Pacific grows fastest.
• Robotics integration advancing vascular and neuro-interventional precision.
• Rise of drug-eluting and bioresorbable stent technologies.
• Increasing prostate artery embolization adoption for BPH treatment.
• Growth in uterine fibroid embolization for reproductive health.
• Hybrid imaging (PET-CT, MRI-guided) enhances treatment precision.
• Expanding liquid embolic agent use in neurovascular procedures.
• Rising chronic disease burden fueling repeat intervention demand.
• Favorable reimbursement policies are boosting non-surgical procedure adoption.
• Growing telemedicine and remote imaging access in underserved regions.

Proceed to Checkout to purchase the exclusive Interventional Radiology Market report and gain instant access to in-depth market intelligence, strategic analysis, and future growth opportunities.

1. Shift Toward Minimally Invasive Procedures
   Hospitals are rapidly replacing open surgeries with catheter-based, image-guided treatments like angioplasty and embolization, cutting patient trauma, shortening recovery time, and lowering overall treatment costs significantly.
2. AI-Powered Imaging and Navigation
   Artificial intelligence embedded in imaging suites enhances real-time procedural guidance, improving accuracy in complex cardiovascular, oncologic, and neurovascular cases while boosting overall procedure volumes globally.
3. Expansion in Oncology Applications
   Oncology remains the largest application segment, with sophisticated embolic agents and ablation technologies improving success rates as global cancer prevalence continues to rise steadily worldwide.
4. Growth of Office-Based Labs and Imaging Centers
   Pay-for-value reimbursement models are shifting procedure volumes away from hospitals toward outpatient imaging centers and ambulatory surgical centers, which are expanding faster than traditional settings.
5. Robotics and Neurovascular Precision
   Robotics is increasingly automating complex vascular and neuro-interventional procedures, elevating treatment precision and consistency, though widespread adoption remains gradual due to specialized training requirements.
6. Regional Growth Divergence
   North America retains the largest revenue share due to mature infrastructure and reimbursement, while Asia-Pacific, led by China and India, grows fastest amid rising healthcare investment.

Top 25 Companies Leading the Interventional Radiology Market 

• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• Terumo Corporation
• Cook Medical
• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Cardinal Health
• Canon Medical Systems Corporation
• Becton, Dickinson and Company
• C.R. Bard (BD)
• Guerbet Group
• Penumbra, Inc.
• Hologic, Inc.
• Merit Medical Systems
• Neuwave Medical, Inc
• Stryker Corporation
• Johnson & Johnson MedTech
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Olympus Corporation
• Teleflex Incorporated
• Shimadzu Corporation
• MicroPort Scientific Corporation

Customize the exclusive Interventional Radiology Market report today to receive tailored insights, country-specific analysis, and business-focused market intelligence.

Top 25 Companies Leading the Interventional Radiology Market

1. Boston Scientific Corporation

This firm excels in manufacturing advanced microcatheters for intricate peripheral vascular procedures.

Founded: 1979 | HQ: Marlborough, Massachusetts, USA.

Why It Ranks: Holds an expansive market share in specialized vascular devices and drug-eluting peripheral technologies.

Regional Dominance: Dominates North American and European clinical markets through extensive distribution networks.

Product Line: Microcatheters, guide wires, peripheral embolization devices, and specialized balloon catheters.

Medtronic plc

A global medical giant pioneering advanced stent grafts for complex aortic treatments.

Founded: 1949 | HQ: Dublin, Ireland.

Why It Ranks: Commands top positions in neurovascular intervention portfolios and high-margin consumable devices.

Regional Dominance: Secures heavy financial revenues across both mature Western and expanding emerging markets.

Product Line: Stents, embolization coils, neurovascular access devices, and continuous ablation systems.

3. Abbott Laboratories

Renowned for engineering elite vessel closure devices that speed post-procedure recovery times.

Founded: 1888 | HQ: Abbott Park, Illinois, USA.

Why It Ranks: Leads market sectors in vascular care therapies and structural heart solutions.

Regional Dominance: Asserts exceptional market control inside major hospital networks throughout North America.

Product Line: Vessel closure systems, diagnostic catheters, coronary stents, and peripheral guide wires.

4. Terumo Corporation

Globally celebrated for high-quality hydrophilic guide wires used in smooth radial access.

Founded: 1921 | HQ: Tokyo, Japan.

Why It Ranks: Unmatched operational reputation for precision manufacturing within the interventional access sector.

Regional Dominance: Maintains an absolute leading market stronghold throughout Japan and broader Asia-Pacific.

Product Line: Hydrophilic guide wires, angiographic catheters, radial access kits, and embolization beads.

5. Cook Medical

A family-owned pioneer dedicated entirely to evolving specialized minimally invasive medical products.

Founded: 1963 | HQ: Bloomington, Indiana, USA.

Why It Ranks: Respected globally for producing an incredibly vast catalog of niche components.

Regional Dominance: Enjoys highly stable, diversified institutional sales across hospitals globally.

Product Line: Vena cava filters, drainage catheters, diagnostic needles, and custom introducer sheaths.

6. Siemens Healthineers

Revolutionizing clinical operating environments through advanced AI-integrated multi-axis robotic angiography platforms.

Founded: 1847 | HQ: Erlangen, Germany.

Why It Ranks: Unrivaled engineering innovator in high-end hybrid operating room imaging infrastructure systems.

Regional Dominance: Commands undisputed market leadership across European hospital imaging system networks.

Product Line: Angiography systems, computed tomography scanners, C-arms, and advanced workflow software.

7. GE Healthcare

This powerhouse delivers elite cloud-based digital imaging solutions for real-time surgical support.

Founded: 1892 | HQ: Chicago, Illinois, USA.

Why It Ranks: Global imaging leader with unparalleled installed device bases across premium hospitals.

Regional Dominance: Generates heavy multi-billion-dollar sales volumes across North American and European territories.

Product Line: Interventional X-ray systems, digital ultrasound platforms, CT scanners, and software.

8. Philips Healthcare

Seamlessly integrating live ultrasound data into advanced X-ray screens for precision.

Founded: 1891 | HQ: Amsterdam, Netherlands.

Why It Ranks: Captures dominant global market shares within the specialized image-guided therapy segment.

Regional Dominance: Retains a massive commercial presence across major global healthcare delivery networks.

Product Line: Azurion image-guided platforms, intravascular ultrasound devices, and specialized interventional software.

9. Cardinal Health

Distributes foundational procedural accessories required globally for daily interventional radiology workflows.

Founded: 1971 | HQ: Dublin, Ohio, USA.

Why It Ranks: Critical supply chain partner providing indispensable standard operational inventory to clinics.

Regional Dominance: Possesses an extensive logistics and supply network spanning the United States.

Product Line: Fluid management tubing, compression devices, biopsy needles, and basic accessories.

10. Canon Medical Systems Corporation

Providing exceptional high-definition Alphenix imaging configurations designed for targeted oncological treatments.

Founded: 1930 | HQ: Otawara, Tochigi, Japan.

Why It Ranks: Renowned for delivering low-dose imaging hardware that maximizes critical patient safety.

Regional Dominance: Expands market footprint rapidly through strategic hospital sales in Asian markets.

Product Line: Angiography configurations, high-resolution CT platforms, ultrasound systems, and workstation software.

Schedule a meeting with our market experts to discuss the exclusive Interventional Radiology Market report and identify the best research solution for your organization.

Conclusion

The interventional radiology market is expected to experience strong growth as the market transitions to minimally invasive procedures and outpatient medical centers. The incorporation of artificial intelligence and robotics into surgery is an integration of unprecedented precision levels, which are considered gold standards in oncology and cardiology. Smart consumables and high-end imaging equipment will continue to blur the lines in an industry that will see sustainable growth over the years. This change will ultimately shape clinical therapy standards and optimise overall patient safety and throughput globally.